This Bispecific T-cell Engager (BiTE) is composed of two scFv domains (one targeting CD19 on malignant B-cells and the other targeting CD3 on T-cells) connected by a linker, to induce a cytolytic synapse between a T-cell and a CD19-positive tumor cell [11]. This evidence concerns the gene CD19 and neoplasm.